Valuation: Photocure ASA

Market Cap 1.58B 161M 141M 131M 121M 229M 15.44B 233M 1.57B 610M 7.56B 605M 592M 26.23B P/E 2026 *
17.3x
P/E 2027 * 35.2x
Enterprise Value 1.34B 137M 120M 111M 102M 194M 13.07B 198M 1.33B 516M 6.4B 513M 502M 22.21B EV / Sales 2026 *
2.03x
EV / Sales 2027 * 1.99x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-1.01%
1 week-0.68%
Current month-0.84%
1 month+2.44%
3 months+0.17%
6 months-22.73%
Current year-17.65%
1 week 58.3
Extreme 58.3
60.3
1 month 56.2
Extreme 56.2
62.1
Current year 55.2
Extreme 55.2
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap.
25-04-01BuyCompany 11,355 0.0419%
25-04-01BuyCompany 8,997 0.0332%
25-03-30BuyCompany 21,105 0.0778%
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%-0.68%+6.33%+25.78% 161M
-1.60%+2.02%+56.34%+168.94% 1,084B
-1.44%+3.71%+69.07%+65.40% 634B
-0.75%+0.67%+33.18%+86.52% 447B
-0.58%-2.58%+27.96%+25.43% 330B
-9.76%-11.76%+23.80%+26.01% 295B
-0.86%-2.55%+27.89%+45.44% 285B
-0.73%-3.72%-27.85%-39.79% 218B
-0.03%+1.84%+23.90%+68.30% 199B
-0.40%+7.82%+22.29%+82.50% 169B
Average -1.26%+2.49%+26.29%+55.45% 366B
Weighted average by Cap. -0.57%+2.48%+39.98%+84.99%

Financials

2026 *2027 *
Net sales 658M 67.13M 58.88M 54.36M 50.23M 95.21M 6.43B 97.11M 653M 254M 3.15B 252M 247M 10.92B 663M 67.64M 59.33M 54.77M 50.61M 95.93M 6.48B 97.85M 658M 256M 3.17B 254M 248M 11B
Net income 92.33M 9.42M 8.26M 7.63M 7.05M 13.36M 902M 13.63M 91.7M 35.63M 441M 35.37M 34.6M 1.53B 45M 4.59M 4.03M 3.72M 3.44M 6.51M 440M 6.64M 44.69M 17.36M 215M 17.24M 16.86M 747M
Net Debt -242M -24.69M -21.65M -19.99M -18.47M -35.02M -2.36B -35.72M -240M -93.38M -1.16B -92.71M -90.68M -4.02B -263M -26.8M -23.5M -21.7M -20.05M -38.01M -2.57B -38.77M -261M -101M -1.26B -101M -98.43M -4.36B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-07-09 NOK 58.80 -1.01% 9,584
26-07-08 NOK 59.40 0.00% 24,378
26-07-07 NOK 59.40 +1.02% 19,126
26-07-06 NOK 58.80 0.00% 16,989
26-07-03 NOK 58.80 -0.68% 28,832
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
59.40NOK
Average target price
84.00NOK
Spread / Average Target
+41.41%

Quarterly revenue - Rate of surprise